W
WAVEMAN · COMPANY
CVS · Cvs Health Corp
> Ask across nine datasets ⌘K
LIVE
TEAM-0.32% 13F +439META+3.01% 13F +2,694RCG-2.04% CLUSTERUTHR-4.03% 13F +425CRWV+4.49% 13F +693CRM+2.92% 13F +1,018CVNA-0.98% 13F +794TPL-0.71% 13F +444NET+4.32% 13F +710MSTR+17.56% 13F +526DELL+4.91% 13F +1,203CRWD+5.68% 13F +1,382ANET+1.22% 13F +1,323COIN+10.14% 13F +475TEAM-0.32% 13F +439META+3.01% 13F +2,694RCG-2.04% CLUSTERUTHR-4.03% 13F +425CRWV+4.49% 13F +693CRM+2.92% 13F +1,018CVNA-0.98% 13F +794TPL-0.71% 13F +444NET+4.32% 13F +710MSTR+17.56% 13F +526DELL+4.91% 13F +1,203CRWD+5.68% 13F +1,382ANET+1.22% 13F +1,323COIN+10.14% 13F +475
← ALL COMPANIES

CVS

CVS HEALTH Corp
WHOLESALE & RETAIL · RETAIL-DRUG STORES AND PROPRIETARY STORES · CIK 0000064803
CONGRESS · 1☆ WATCH
INSIDER NET · 180D
-$323.7M
open-market buys minus sells, Form 4 codes P and S
INSIDER BUYERS · 180D
0
CONGRESS BUYERS · 1Y
1
FUNDS ADDED · QTR
1,103
13F, latest reported quarter
REVENUE GROWTH
+7.8%
XBRL, annual
NET MARGIN
0.4%
SEVEN FACTS, RANKED AGAINST THE SECTOR · RANK IS NOT A FORECAST
INSIDERS
net -$323.7M over 180 days
below 97% of Wholesale & Retail
CONGRESS
1 member bought in the last year
the lowest in Wholesale & Retail
FUNDS
1,103 funds added or opened last quarter
more than 98% of Wholesale & Retail
REVENUE
+7.8% year over year
more than 66% of Wholesale & Retail
MARGIN
0.4% net margin
below 58% of Wholesale & Retail
BUYBACKS
no share repurchases reported
SHORT
1.5% of shares outstanding short · 2.4 days to cover · settled 2026-07-31
below 64% of Wholesale & Retail
THE SITUATION · EVERY LINE IS ONE RULE OVER ONE DATASET
1,103 funds added or opened positions in the latest 13F quarter, of 2,070 holders.
1 member of Congress reported buying it this year.
The year, with the filings on it
Total return indexed to 100 over the last 12 months · every marker is a federal filing, placed at its date — hover any marker for the detail
TOTAL 12M RETURN +35.4%
+35.4%12M
-5%+14%+34%+53%2025-092025-102025-122026-032026-052026-072026-09 2026-05-19 · ROBBINS LARRY sold $187.3M2026-05-20 · ROBBINS LARRY sold $74.6M2026-05-21 · ROBBINS LARRY sold $34.6M2026-05-20 · ROBBINS LARRY sold $14.5M2026-05-20 · ROBBINS LARRY sold $6.4M2026-05-08 · Mandadi Tilak sold $6.2M2026-05-20 · ROBBINS LARRY sold $77.0K2026-05-19 · ROBBINS LARRY sold $14.4K
INSIDER SELL
INDEXED RETURN, DIVIDEND-ADJUSTED — NOT A PRICE CHART · LARGE TRADES DRAWN FIRST WHEN A NAME FILES HEAVILY
Live price
Daily candles from TradingView, on their licence — no filings are marked on this one
WHY THIS NAME IS ON THE DESK
The complete filing record, in one place.
The record shows a net $323.7M sold by insiders over 180 days, 1,103 funds added last quarter, 1 Congress member(s) bought in 12 months. Every figure is a federal filing, dated the day it became public.
Same sector, ranked by filing activity
Sector from the SEC's own SIC classification
Insider transactions
Form 4 purchases and sales (codes P and S) — grants, option exercises and preferred conversions excluded

Over the last 180 days, CVS HEALTH Corp insiders sold a net $323.7M of stock across 62 Form 4 purchases and sales, with 0 insider(s) buying. Source: SEC Form 4 filings, as of 2026-09-05.

INSIDER
FILED
SHARES
VALUE
ROBBINS LARRY
Director
SELL
2026-05-21
370,462.0
$34.6M
ROBBINS LARRY
Director
SELL
2026-05-20
66,881.0
$6.4M
ROBBINS LARRY
Director
SELL
2026-05-20
800.0
$77.0K
ROBBINS LARRY
Director
SELL
2026-05-20
797,628.0
$74.6M
ROBBINS LARRY
Director
SELL
2026-05-20
152,691.0
$14.5M
62 TRANSACTIONS ON RECORD

Showing the most recent few. Create a free account to see 57 more transactions on record, the cross-source screener and CSV export. We store only your email address, and there is no password to create.

Institutional holders
13F · holdings as of the latest quarter funds have reported
BlackRock, Inc.
123,223,409.0 sh
$12.7B
VANGUARD CAPITAL MANAGEMENT LLC
83,315,369.0 sh
$8.6B
Capital World Investors
74,951,955.0 sh
$7.8B
STATE STREET CORP
60,283,408.0 sh
$6.2B
Dodge & Cox
50,012,765.0 sh
$5.2B
SCHEDULE 13D/G
No 5%+ ownership filings
Nobody has crossed 5% with a filing obligation. Absence is a fact here, not missing data.
FORM 144
No planned-sale notices
No insider has notified an intent to sell. This is the panel to watch after a run-up.
Fund concentration
N-PORT · funds ranked by how much of THEMSELVES they put in this stock — the conviction number 13F cannot show
iShares U.S. Healthcare Providers ETF
$82.9M POSITION · AS OF 2026-03-31
12.8%
Select Health Care Services Portfolio
$85.6M POSITION · AS OF 2026-02-28
10.5%
Classic Value Fund
$27.1M POSITION · AS OF 2026-04-30
5.4%
Twin Oak Strategic Solutions ETF
$8.3M POSITION · AS OF 2026-02-28
4.9%
Madison Covered Call & Equity Income Fund
$6.5M POSITION · AS OF 2026-04-30
4.6%
Davis Select U.S. Equity ETF
$53.0M POSITION · AS OF 2026-04-30
4.6%
SEC N-PORT, MONTHLY WITH A ~60-DAY PUBLIC LAG · FUNDS ≥ $10M · % = SHARE OF THE FUND'S OWN BOOK
Corporate PAC
FEC · the company-connected political action committee's own receipts and spending — committee totals only, never individual donors
Cvs Health Pac
CYCLE 2026 · $1,192K SPENT
$1.3M
FEDERAL ELECTION COMMISSION · MATCHED BY THE PAC'S CONNECTED ORGANISATION
Fundamentals
Annual figures from XBRL filings · pick a past date to see them exactly as the market knew them then — restatements and all
2025-122024-122023-122022-12
REVENUE$402.1B$372.8B$357.8B$322.5B
OPERATING INCOME$4.7B$8.5B$13.7B$8.0B
NET INCOME$1.8B$4.6B$8.3B$4.3B
EPS (DILUTED)1.393.666.473.26
OPERATING CASH FLOW$10.6B$9.1B$13.4B$16.2B
CASH$8.5B$8.6B$8.2B$12.9B
BUYBACKS$0$3.0B$2.0B$3.5B
DIVIDENDS PAID$3.4B$3.4B$3.1B$2.9B
SEC XBRL · FISCAL-YEAR PERIODS · AS KNOWN ON 2026-09-05 · NOBODY ELSE SHOWS FUNDAMENTALS AS OF A PAST DATE
W WAVEMAN

Public filings, honestly analyzed. Official US government sources in one desk — every figure carries the date it was filed, and the methodology is published, backtest included.

SEC FORM 4FORM 13F 13D/GFORM 144XBRL STOCK ACTCONTRACTSFEC CFPBNRC
© 2026 WAVEMAN · SOURCE: SEC EDGAR & OFFICIAL GOVERNMENT DATA · NOT INVESTMENT ADVICE · CHART BY TRADINGVIEW · UPDATED 2026-09-05 ALL SYSTEMS LIVE FOR MACHINES →